<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikianesthesia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Huckfinne</id>
	<title>WikiAnesthesia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wikianesthesia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Huckfinne"/>
	<link rel="alternate" type="text/html" href="https://wikianesthesia.org/wiki/Special:Contributions/Huckfinne"/>
	<updated>2026-05-01T18:48:59Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.37.1</generator>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Desmopressin&amp;diff=13374</id>
		<title>Desmopressin</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Desmopressin&amp;diff=13374"/>
		<updated>2022-07-18T18:41:39Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: Create page&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
Provide a brief summary of this drug here.&lt;br /&gt;
&lt;br /&gt;
==Uses&amp;lt;!--Describe uses of the drug. If appropriate, add subsections for each indication.--&amp;gt;==&lt;br /&gt;
==Contraindications&amp;lt;!--List contraindications and precautions for use of the drug.--&amp;gt;==&lt;br /&gt;
===Absolute contraindications&amp;lt;!--List absolute contraindications for use of the drug. If none, this section may be removed.--&amp;gt;===&lt;br /&gt;
===Precautions&amp;lt;!--List precautions for use of the drug. If none, this section may be removed.--&amp;gt;===&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
===Pharmacodynamics&amp;lt;!--Describe the effects of the drug on the body. If appropriate, add subsections by organ system--&amp;gt;===&lt;br /&gt;
====Mechanism of action&amp;lt;!--Describe the mechanism of action for the primary uses of the drug.--&amp;gt;====&lt;br /&gt;
V2 receptor agonist without any V1 activity&lt;br /&gt;
&lt;br /&gt;
====Adverse effects&amp;lt;!--Describe any potential adverse effects of the drug.--&amp;gt;====&lt;br /&gt;
===Pharmacokinetics&amp;lt;!--Describe the pharmacokinetics of the drug.--&amp;gt;===&lt;br /&gt;
==Chemistry and formulation&amp;lt;!--Describe the chemistry and formulation of the drug.--&amp;gt;==&lt;br /&gt;
==History&amp;lt;!--Describe the historical development of the drug.--&amp;gt;==&lt;br /&gt;
==References==&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Dexmedetomidine&amp;diff=13373</id>
		<title>Dexmedetomidine</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Dexmedetomidine&amp;diff=13373"/>
		<updated>2022-07-18T17:50:21Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: add minor bits for MOA.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Infobox drug reference&lt;br /&gt;
| trade_names = &lt;br /&gt;
| image_file = Dexmedetomidine.svg&lt;br /&gt;
| drug_class = Sedative hypnotic&lt;br /&gt;
| drug_class_color = sedative_hypnotic&lt;br /&gt;
| uses = &lt;br /&gt;
| contraindications = &lt;br /&gt;
| routes = IV, IM, IN&lt;br /&gt;
| dosage = &lt;br /&gt;
| dosage_calculation = dexmedetomidine&lt;br /&gt;
| mechanism = Alpha-2 agonism&lt;br /&gt;
| adverse_effects = &lt;br /&gt;
| time_onset = &lt;br /&gt;
| duration = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| halflife_redistribution = &lt;br /&gt;
| halflife_elimination = &lt;br /&gt;
| clearance = &lt;br /&gt;
| protein_binding = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
Provide a brief summary of this drug here.&lt;br /&gt;
&lt;br /&gt;
== Uses&amp;lt;!-- Describe uses of the drug. If appropriate, add subsections for each indication. --&amp;gt; ==&lt;br /&gt;
ICU, intra-operative, and procedural sedation without respiratory depression or amnestic properties.  May decrease opioid requirement, more so due to sedating rather than analgesic effects.&lt;br /&gt;
&lt;br /&gt;
==Contraindications&amp;lt;!-- List contraindications and precautions for use of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
===Absolute contraindications&amp;lt;!-- List absolute contraindications for use of the drug. If none, this section may be removed. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
===Precautions&amp;lt;!-- List precautions for use of the drug. If none, this section may be removed. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
&lt;br /&gt;
===Pharmacodynamics&amp;lt;!-- Describe the effects of the drug on the body. If appropriate, add subsections by organ system --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Mechanism of action&amp;lt;!-- Describe the mechanism of action for the primary uses of the drug. --&amp;gt;====&lt;br /&gt;
Central α-2 agonist with a 1600:1 affinity for α-2 receptors over α-1 receptors.  &lt;br /&gt;
&lt;br /&gt;
====Adverse effects&amp;lt;!-- Describe any potential adverse effects of the drug. --&amp;gt;====&lt;br /&gt;
Risk of hypotension and bradycardia, in a dose-dependent manner.  Night terrors and transient behavioral effects in children have been reported when used for pre-anesthetic sedation, due to calming effects without amnestic properties.&lt;br /&gt;
&lt;br /&gt;
===Pharmacokinetics&amp;lt;!-- Describe the pharmacokinetics of the drug. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
==Chemistry and formulation&amp;lt;!-- Describe the chemistry and formulation of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==History&amp;lt;!-- Describe the historical development of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Drug reference]]&lt;br /&gt;
[[Category:Sedative hypnotics]]&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Craniotomy_for_trauma&amp;diff=13365</id>
		<title>Craniotomy for trauma</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Craniotomy_for_trauma&amp;diff=13365"/>
		<updated>2022-07-18T15:04:05Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: add reference&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Infobox surgical procedure&lt;br /&gt;
| anesthesia_type = General&lt;br /&gt;
| airway = ETT&lt;br /&gt;
| lines_access = large bore PIV, arterial line, consider central line if poor peripheral access or long term infusions required, ICP drain/monitor&lt;br /&gt;
| monitors = Standard plus arterial line and ICP monitoring&lt;br /&gt;
| considerations_preoperative = Full stomach, preop neuro exam&lt;br /&gt;
| considerations_intraoperative = bleeding, ICP changes&lt;br /&gt;
| considerations_postoperative = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
Provide a brief summary of this surgical procedure and its indications here.&lt;br /&gt;
&lt;br /&gt;
== Preoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Patient evaluation&amp;lt;!-- Describe the unique and important aspects of preoperative evaluation. Add or remove rows from the systems table as needed. --&amp;gt; ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!System&lt;br /&gt;
!Considerations&lt;br /&gt;
|-&lt;br /&gt;
|Airway&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Neurologic&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cardiovascular&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Pulmonary&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Gastrointestinal&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hematologic&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Renal&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Endocrine&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Other&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Labs and studies&amp;lt;!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
Preop: CBC for baseline hemoglobin, CMP for electrolytes including sodium and potassium, INR given possible anticoagulants use&lt;br /&gt;
&lt;br /&gt;
Intraop: Serial hemoglobin. Consider frequent Na checks if utilizing hypertonic saline, K checks if hyperventilating. TEG/coagulation studies as needed for resuscitation &lt;br /&gt;
&lt;br /&gt;
=== Operating room setup&amp;lt;!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
General anesthesia setup including fluid warmer/blood tubing, arterial line monitoring/setup, multiple infusion pumps, and consider ICP monitoring/drain as guided by neurosurgery. &lt;br /&gt;
&lt;br /&gt;
=== Patient preparation and premedication&amp;lt;!-- Describe any unique considerations for patient preparation and premedication. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Regional and neuraxial techniques&amp;lt;!-- Describe any potential regional and/or neuraxial techniques which may be used for this case. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Intraoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Monitoring and access&amp;lt;!-- List and/or describe monitors and access typically needed for this case. Please describe rationale for any special monitors or access. --&amp;gt; ===&lt;br /&gt;
Needs arterial line&lt;br /&gt;
&lt;br /&gt;
Consider ICP monitoring as guided by neurosurgery &lt;br /&gt;
&lt;br /&gt;
=== Induction and airway management&amp;lt;!-- Describe the important considerations and general approach to the induction of anesthesia and how the airway is typically managed for this case. --&amp;gt; ===&lt;br /&gt;
Avoid increased ICP during induction &lt;br /&gt;
&lt;br /&gt;
=== Positioning&amp;lt;!-- Describe any unique positioning considerations, including potential intraoperative position changes. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Maintenance and surgical considerations&amp;lt;!-- Describe the important considerations and general approach to the maintenance of anesthesia, including potential complications. Be sure to include any steps to the surgical procedure that have anesthetic implications. --&amp;gt; ===&lt;br /&gt;
ICP monitoring and possible reduction including:&lt;br /&gt;
&lt;br /&gt;
* ICP draining&lt;br /&gt;
* Hyperventilation&lt;br /&gt;
* Steroids&lt;br /&gt;
* Antileptics &lt;br /&gt;
* Mannitol&lt;br /&gt;
* Hypertonic saline &lt;br /&gt;
* Head of bed position (as possible) &lt;br /&gt;
*Avoid using albumin due to increased mortality. &lt;br /&gt;
&lt;br /&gt;
=== Emergence&amp;lt;!-- List and/or describe any important considerations related to the emergence from anesthesia for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Postoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Disposition&amp;lt;!-- List and/or describe the postoperative disposition and any special considerations for transport of patients for this case. --&amp;gt; ===&lt;br /&gt;
Neuro critical care unit &lt;br /&gt;
&lt;br /&gt;
=== Pain management&amp;lt;!-- Describe the expected level of postoperative pain and approaches to pain management for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Potential complications&amp;lt;!-- List and/or describe any potential postoperative complications for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Procedure variants&amp;lt;!-- This section should only be used for cases with multiple approaches (e.g. Laparoscopic vs. open appendectomy). Otherwise, remove this section. Use this table to very briefly compare and contrast various aspects between approaches. Add or remove rows as needed to maximize relevance. Consider using symbols rather than words when possible (e.g. +, –, additional symbols such as ↑ and ↓ are available using the &amp;quot;Ω&amp;quot; tool in the editor). --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable wikitable-horizontal-scroll&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!&lt;br /&gt;
!Variant 1&lt;br /&gt;
!Variant 2&lt;br /&gt;
|-&lt;br /&gt;
|Unique considerations&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Position&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Surgical time&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|EBL&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Postoperative disposition&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Pain management&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Potential complications&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
https://pubmed.ncbi.nlm.nih.gov/23194432/&lt;br /&gt;
[[Category:Surgical procedures]]&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Craniotomy_for_trauma&amp;diff=13364</id>
		<title>Craniotomy for trauma</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Craniotomy_for_trauma&amp;diff=13364"/>
		<updated>2022-07-18T15:03:04Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Infobox surgical procedure&lt;br /&gt;
| anesthesia_type = General&lt;br /&gt;
| airway = ETT&lt;br /&gt;
| lines_access = large bore PIV, arterial line, consider central line if poor peripheral access or long term infusions required, ICP drain/monitor&lt;br /&gt;
| monitors = Standard plus arterial line and ICP monitoring&lt;br /&gt;
| considerations_preoperative = Full stomach, preop neuro exam&lt;br /&gt;
| considerations_intraoperative = bleeding, ICP changes&lt;br /&gt;
| considerations_postoperative = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
Provide a brief summary of this surgical procedure and its indications here.&lt;br /&gt;
&lt;br /&gt;
== Preoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Patient evaluation&amp;lt;!-- Describe the unique and important aspects of preoperative evaluation. Add or remove rows from the systems table as needed. --&amp;gt; ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!System&lt;br /&gt;
!Considerations&lt;br /&gt;
|-&lt;br /&gt;
|Airway&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Neurologic&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cardiovascular&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Pulmonary&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Gastrointestinal&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hematologic&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Renal&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Endocrine&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Other&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Labs and studies&amp;lt;!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
Preop: CBC for baseline hemoglobin, CMP for electrolytes including sodium and potassium, INR given possible anticoagulants use&lt;br /&gt;
&lt;br /&gt;
Intraop: Serial hemoglobin. Consider frequent Na checks if utilizing hypertonic saline, K checks if hyperventilating. TEG/coagulation studies as needed for resuscitation &lt;br /&gt;
&lt;br /&gt;
=== Operating room setup&amp;lt;!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
General anesthesia setup including fluid warmer/blood tubing, arterial line monitoring/setup, multiple infusion pumps, and consider ICP monitoring/drain as guided by neurosurgery. &lt;br /&gt;
&lt;br /&gt;
=== Patient preparation and premedication&amp;lt;!-- Describe any unique considerations for patient preparation and premedication. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Regional and neuraxial techniques&amp;lt;!-- Describe any potential regional and/or neuraxial techniques which may be used for this case. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Intraoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Monitoring and access&amp;lt;!-- List and/or describe monitors and access typically needed for this case. Please describe rationale for any special monitors or access. --&amp;gt; ===&lt;br /&gt;
Needs arterial line&lt;br /&gt;
&lt;br /&gt;
Consider ICP monitoring as guided by neurosurgery &lt;br /&gt;
&lt;br /&gt;
=== Induction and airway management&amp;lt;!-- Describe the important considerations and general approach to the induction of anesthesia and how the airway is typically managed for this case. --&amp;gt; ===&lt;br /&gt;
Avoid increased ICP during induction &lt;br /&gt;
&lt;br /&gt;
=== Positioning&amp;lt;!-- Describe any unique positioning considerations, including potential intraoperative position changes. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Maintenance and surgical considerations&amp;lt;!-- Describe the important considerations and general approach to the maintenance of anesthesia, including potential complications. Be sure to include any steps to the surgical procedure that have anesthetic implications. --&amp;gt; ===&lt;br /&gt;
ICP monitoring and possible reduction including:&lt;br /&gt;
&lt;br /&gt;
* ICP draining&lt;br /&gt;
* Hyperventilation&lt;br /&gt;
* Steroids&lt;br /&gt;
* Antileptics &lt;br /&gt;
* Mannitol&lt;br /&gt;
* Hypertonic saline &lt;br /&gt;
* Head of bed position (as possible) &lt;br /&gt;
*Avoid using albumin due to increased mortality. &lt;br /&gt;
&lt;br /&gt;
=== Emergence&amp;lt;!-- List and/or describe any important considerations related to the emergence from anesthesia for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Postoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Disposition&amp;lt;!-- List and/or describe the postoperative disposition and any special considerations for transport of patients for this case. --&amp;gt; ===&lt;br /&gt;
Neuro critical care unit &lt;br /&gt;
&lt;br /&gt;
=== Pain management&amp;lt;!-- Describe the expected level of postoperative pain and approaches to pain management for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Potential complications&amp;lt;!-- List and/or describe any potential postoperative complications for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Procedure variants&amp;lt;!-- This section should only be used for cases with multiple approaches (e.g. Laparoscopic vs. open appendectomy). Otherwise, remove this section. Use this table to very briefly compare and contrast various aspects between approaches. Add or remove rows as needed to maximize relevance. Consider using symbols rather than words when possible (e.g. +, –, additional symbols such as ↑ and ↓ are available using the &amp;quot;Ω&amp;quot; tool in the editor). --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable wikitable-horizontal-scroll&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!&lt;br /&gt;
!Variant 1&lt;br /&gt;
!Variant 2&lt;br /&gt;
|-&lt;br /&gt;
|Unique considerations&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Position&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Surgical time&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|EBL&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Postoperative disposition&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Pain management&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Potential complications&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
[[Category:Surgical procedures]]&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Terbutaline&amp;diff=13361</id>
		<title>Terbutaline</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Terbutaline&amp;diff=13361"/>
		<updated>2022-07-18T14:13:06Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: add adverse effects&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Infobox drug reference&lt;br /&gt;
| trade_names = &lt;br /&gt;
| drug_class = Beta agonist&lt;br /&gt;
| drug_class_color = cardiovascular_agonist&lt;br /&gt;
| uses = Tocolysis&lt;br /&gt;
| contraindications = &lt;br /&gt;
| routes = IV, SC&lt;br /&gt;
| dosage = &lt;br /&gt;
| dosage_calculation = terbutaline&lt;br /&gt;
| mechanism = Beta-2 agonism&lt;br /&gt;
| adverse_effects = &lt;br /&gt;
| time_onset = &lt;br /&gt;
| duration = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| halflife_redistribution = &lt;br /&gt;
| halflife_elimination = &lt;br /&gt;
| clearance = &lt;br /&gt;
| protein_binding = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
Provide a brief summary of this drug here.&lt;br /&gt;
&lt;br /&gt;
==Uses&amp;lt;!-- Describe uses of the drug. If appropriate, add subsections for each indication. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==Contraindications&amp;lt;!-- List contraindications and precautions for use of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
===Absolute contraindications&amp;lt;!-- List absolute contraindications for use of the drug. If none, this section may be removed. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
===Precautions&amp;lt;!-- List precautions for use of the drug. If none, this section may be removed. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
&lt;br /&gt;
===Pharmacodynamics&amp;lt;!-- Describe the effects of the drug on the body. If appropriate, add subsections by organ system --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Mechanism of action&amp;lt;!-- Describe the mechanism of action for the primary uses of the drug. --&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
====Adverse effects&amp;lt;!-- Describe any potential adverse effects of the drug. --&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
* Hyperglycemia&lt;br /&gt;
* Hypokalemia&lt;br /&gt;
* Tachycardia&lt;br /&gt;
&lt;br /&gt;
===Pharmacokinetics&amp;lt;!-- Describe the pharmacokinetics of the drug. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
==Chemistry and formulation&amp;lt;!-- Describe the chemistry and formulation of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==History&amp;lt;!-- Describe the historical development of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Drug reference]]&lt;br /&gt;
[[Category:Adrenergic receptor modulators]]&lt;br /&gt;
[[Category:Beta agonists]]&lt;br /&gt;
[[Category:Beta-2 agonists]]&lt;br /&gt;
[[Category:Tocolytics]]&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Opioids&amp;diff=13346</id>
		<title>Opioids</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Opioids&amp;diff=13346"/>
		<updated>2022-07-17T23:44:55Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: add opioid receptors&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==List of common opioids==&lt;br /&gt;
&lt;br /&gt;
===Receptors===&lt;br /&gt;
μ1 - euphoria&lt;br /&gt;
&lt;br /&gt;
μ2 - hypoventilation, constipation, dependent&lt;br /&gt;
&lt;br /&gt;
δ - hypoventilation, constipation, dependent&lt;br /&gt;
&lt;br /&gt;
κ - antagonize many of the μ effects and engenders diuresis&lt;br /&gt;
&lt;br /&gt;
σ - dysphoria&lt;br /&gt;
&lt;br /&gt;
===Opium alkaloids and semisynthetic derivatives===&lt;br /&gt;
&lt;br /&gt;
====Opium alkaloids====&lt;br /&gt;
*[[Codeine]]&lt;br /&gt;
*[[Codeine|Morphine]]&lt;br /&gt;
&lt;br /&gt;
====Semisynthetic derivatives====&lt;br /&gt;
*[[Buprenorphine]] (partial agonist)&lt;br /&gt;
*[[Hydrocodone]]&lt;br /&gt;
*[[Hydromorphone]]&lt;br /&gt;
*[[Naloxone]] (antagonist)&lt;br /&gt;
*[[Naltrexone]] (antagonist)&lt;br /&gt;
*[[Oxycodone]]&lt;br /&gt;
&lt;br /&gt;
===Synthetic opioids===&lt;br /&gt;
*[[Alfentanil]]&lt;br /&gt;
*[[Fentanyl]]&lt;br /&gt;
*[[Meperidine]]&lt;br /&gt;
*[[Methadone]]&lt;br /&gt;
*[[Remifentanil]]&lt;br /&gt;
*[[Sufentanil]]&lt;br /&gt;
&lt;br /&gt;
==Molecular structure==&lt;br /&gt;
&amp;lt;gallery widths=&amp;quot;150px&amp;quot; heights=&amp;quot;150px&amp;quot; perrow=&amp;quot;4&amp;quot; caption=&amp;quot;Molecular structure of opium alkaloids&amp;quot;&amp;gt;&lt;br /&gt;
File:Codeine.svg|[[Codeine]]&lt;br /&gt;
File:Morphine.svg|[[Morphine]]&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&amp;lt;gallery widths=&amp;quot;150px&amp;quot; heights=&amp;quot;150px&amp;quot; perrow=&amp;quot;4&amp;quot; caption=&amp;quot;Molecular structure of semisynthetic derivatives&amp;quot;&amp;gt;&lt;br /&gt;
File:Hydrocodone.svg|[[Hydrocodone]]&lt;br /&gt;
File:Hydromorphone.svg|[[Hydromorphone]]&lt;br /&gt;
File:Oxycodone.svg|[[Oxycodone]]&lt;br /&gt;
File:Naloxone.svg|[[Naloxone]] (antagonist)&lt;br /&gt;
File:Naltrexone.svg|[[Naltrexone]] (antagonist)&lt;br /&gt;
File:Buprenorphine.svg|[[Buprenorphine]] (partial agonist)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&amp;lt;gallery widths=&amp;quot;150px&amp;quot; heights=&amp;quot;150px&amp;quot; perrow=&amp;quot;4&amp;quot; caption=&amp;quot;Molecular structure of anilidopiperidine opioids&amp;quot;&amp;gt;&lt;br /&gt;
File:Alfentanil.svg|[[Alfentanil]]&lt;br /&gt;
File:Fentanyl.svg|[[Fentanyl]]&lt;br /&gt;
File:Remifentanil.svg|[[Remifentanil]]&lt;br /&gt;
File:Sufentanil.svg|[[Sufentanil]]&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&amp;lt;gallery widths=&amp;quot;150px&amp;quot; heights=&amp;quot;150px&amp;quot; perrow=&amp;quot;4&amp;quot; caption=&amp;quot;Molecular structure of other synthetic opioids&amp;quot;&amp;gt;&lt;br /&gt;
File:Meperidine.svg|[[Meperidine]]&lt;br /&gt;
File:Methadone.svg|[[Methadone]]&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Succinylcholine&amp;diff=13345</id>
		<title>Succinylcholine</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Succinylcholine&amp;diff=13345"/>
		<updated>2022-07-17T23:41:21Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: add absolute contraindications&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Infobox drug reference&lt;br /&gt;
| trade_names = Anectine&lt;br /&gt;
| drug_class = Depolarizing neuromuscular blocker&lt;br /&gt;
| drug_class_color = succinylcholine&lt;br /&gt;
| uses = Paralysis for intubation&lt;br /&gt;
| contraindications = History/risk of [[Malignant hyperthermia|malignant hyperthermia]]&amp;lt;br /&amp;gt;&lt;br /&gt;
Conditions which proliferate extrajunctional acetylcholine receptors&lt;br /&gt;
| routes = Intravenous, intramuscular&lt;br /&gt;
| dosage = &lt;br /&gt;
| halflife_elimination = &lt;br /&gt;
| image_file = Succinylcholine.svg&lt;br /&gt;
| protein_binding = &lt;br /&gt;
| clearance = &lt;br /&gt;
| time_onset = 30-60 seconds (IV)&amp;lt;br /&amp;gt;&lt;br /&gt;
2-3 minutes (IM)&lt;br /&gt;
| halflife_redistribution = &lt;br /&gt;
| metabolism = Plasma cholinesterase&lt;br /&gt;
| duration = 5-10 minutes (IV)&amp;lt;br /&amp;gt;&lt;br /&gt;
10-30 minutes (IM)&lt;br /&gt;
| adverse_effects = Bradycardia, hyperkalemia, malignant hyperthermia, myalgias&lt;br /&gt;
| dosage_calculation = succinylcholine&lt;br /&gt;
| mechanism = Depolarizing blockade of neuromuscular junction&lt;br /&gt;
| formula = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
'''Succinylcholine''', also known as '''suxamethonium''', is a short-acting neuromuscular blocker used during intubation.&lt;br /&gt;
&lt;br /&gt;
==Uses&amp;lt;!-- Describe uses of the drug. If appropriate, add subsections for each indication. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==Contraindications&amp;lt;!-- List contraindications and precautions for use of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
===Absolute contraindications&amp;lt;!-- List absolute contraindications for use of the drug. If none, this section may be removed. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
* hyperkalemia&lt;br /&gt;
* increased risk of [[Malignant Hyperthermia|malignant hyperthermia]]&lt;br /&gt;
* open globe injury&lt;br /&gt;
* allergy&lt;br /&gt;
&lt;br /&gt;
===Precautions&amp;lt;!-- List precautions for use of the drug. If none, this section may be removed. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
&lt;br /&gt;
===Pharmacodynamics&amp;lt;!-- Describe the effects of the drug on the body. If appropriate, add subsections by organ system --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Mechanism of action&amp;lt;!-- Describe the mechanism of action for the primary uses of the drug. --&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
====Adverse effects&amp;lt;!-- Describe any potential adverse effects of the drug. --&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
===Pharmacokinetics&amp;lt;!-- Describe the pharmacokinetics of the drug. --&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
==Chemistry and formulation&amp;lt;!-- Describe the chemistry and formulation of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==History&amp;lt;!-- Describe the historical development of the drug. --&amp;gt;==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
[[Category:Drug reference]]&lt;br /&gt;
[[Category:Neuromuscular blockers]]&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Mastectomy&amp;diff=3188</id>
		<title>Mastectomy</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Mastectomy&amp;diff=3188"/>
		<updated>2021-11-04T21:27:15Z</updated>

		<summary type="html">&lt;p&gt;Huckfinne: add no airway&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Infobox surgical case reference&lt;br /&gt;
| anesthesia_type = General&lt;br /&gt;
| airway = ETT vs. LMA vs. spontaneous&lt;br /&gt;
| lines_access = PIV x 1-2&lt;br /&gt;
| monitors = Standard monitors&lt;br /&gt;
| considerations_preoperative = Place IV in non-operative extremity&lt;br /&gt;
| considerations_intraoperative = &lt;br /&gt;
| considerations_postoperative = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
A total '''mastectomy''' (simple mastectomy) refers to the complete removal of breast tissue.  A modified radical mastectomy refers to the removal of the breast and the corresponding axillary lymph nodes.   &lt;br /&gt;
&lt;br /&gt;
== Preoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Patient evaluation&amp;lt;!-- Describe the unique and important aspects of preoperative evaluation. Add or remove rows from the systems table as needed. --&amp;gt; ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!System&lt;br /&gt;
!Considerations&lt;br /&gt;
|-&lt;br /&gt;
|Neurologic&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cardiovascular&lt;br /&gt;
|Chemotherapy (ex. anthracyclines) can cause cardiomyopathy that is often irreversible. Use of trastuzamab can cause reversible decrease in LV function.&lt;br /&gt;
|-&lt;br /&gt;
|Respiratory&lt;br /&gt;
|Patients receiving radiation therapy to the chest/thorax can have respiratory compromise &lt;br /&gt;
|-&lt;br /&gt;
|Gastrointestinal&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hematologic&lt;br /&gt;
|Chemotherapy can cause anemia and thrombocytopenia. &lt;br /&gt;
|-&lt;br /&gt;
|Renal&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Endocrine&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Other&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Labs and studies&amp;lt;!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* CBC with diff and platelet count &lt;br /&gt;
** May have anemia or thrombocytopenia due to chemo&lt;br /&gt;
* EKG &lt;br /&gt;
* Consider echo &lt;br /&gt;
** May have cardiomyopathy due to chemotherapy&lt;br /&gt;
&lt;br /&gt;
=== Operating room setup&amp;lt;!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Patient preparation and premedication&amp;lt;!-- Describe any unique considerations for patient preparation and premedication. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* Consider acetaminophen, gabapentin and/or celecoxib&lt;br /&gt;
* Anxiolysis, as needed&lt;br /&gt;
* ERAS protocol&lt;br /&gt;
&lt;br /&gt;
=== Regional and neuraxial techniques&amp;lt;!-- Describe any potential regional and/or neuraxial techniques which may be used for this case. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* Consider paravertebral blocks, transversus abdomens plane (TAP) block, or thoracic epidural&lt;br /&gt;
* Studies have shown a trend towards increasing utilization of peripheral nerve blocks (PNB) for mastectomy.  As of 2018, ~13% of cases involved a PNB according to the National Anesthesia Clinical Outcomes Registry&amp;lt;ref&amp;gt;{{Cite journal|last=Lam|first=Stephanie|last2=Qu|first2=Helena|last3=Hannum|first3=Margaret|last4=Tan|first4=Kay See|last5=Afonso|first5=Anoushka|last6=Tokita|first6=Hanae K.|last7=McCormick|first7=Patrick J.|date=2021-05-24|title=Trends in Peripheral Nerve Block Usage in Mastectomy and Lumpectomy: Analysis of a National Database From 2010 to 2018|url=https://journals.lww.com/anesthesia-analgesia/Abstract/9900/Trends_in_Peripheral_Nerve_Block_Usage_in.56.aspx|journal=Anesthesia &amp;amp; Analgesia|language=en-US|pages=10.1213/ANE.0000000000005368|doi=10.1213/ANE.0000000000005368|issn=0003-2999}}&amp;lt;/ref&amp;gt;.  &lt;br /&gt;
&lt;br /&gt;
== Intraoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Monitoring and access&amp;lt;!-- List and/or describe monitors and access typically needed for this case. Please describe rationale for any special monitors or access. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* PIV x 1-2 (non-operative extremity)&lt;br /&gt;
* Place BP cuff on non-operative extremity&lt;br /&gt;
&lt;br /&gt;
=== Induction and airway management&amp;lt;!-- Describe the important considerations and general approach to the induction of anesthesia and how the airway is typically managed for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* Standard induction&lt;br /&gt;
&lt;br /&gt;
=== Positioning&amp;lt;!-- Describe any unique positioning considerations, including potential intraoperative position changes. If none, this section may be removed. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* Supine &lt;br /&gt;
* Ipsilateral arm may be prepped into field&lt;br /&gt;
* Repositioning may be required &lt;br /&gt;
* Avoid brachial plexus stretch&lt;br /&gt;
* Repositioning may be required if reconstruction is also being done (i.e. latissimus doors flap)&lt;br /&gt;
&lt;br /&gt;
=== Maintenance and surgical considerations&amp;lt;!-- Describe the important considerations and general approach to the maintenance of anesthesia, including potential complications. Be sure to include any steps to the surgical procedure that have anesthetic implications. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* Standard maintenance&lt;br /&gt;
* Surgeon may prefer no paralytic for the axillary direction&lt;br /&gt;
* Maintain normovolemia -goal-directed fluid management &lt;br /&gt;
* Maintain normothermia - warming blanket&lt;br /&gt;
* Avoid anemia and blood transfusions&lt;br /&gt;
* Watch out for potential pneumothorax with deep surgical exploration&lt;br /&gt;
&lt;br /&gt;
=== Emergence&amp;lt;!-- List and/or describe any important considerations related to the emergence from anesthesia for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* PONV prophylaxis (females are more susceptible to PONV)&lt;br /&gt;
&lt;br /&gt;
== Postoperative management ==&lt;br /&gt;
&lt;br /&gt;
=== Disposition&amp;lt;!-- List and/or describe the postoperative disposition and any special considerations for transport of patients for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* PACU&lt;br /&gt;
&lt;br /&gt;
=== Pain management&amp;lt;!-- Describe the expected level of postoperative pain and approaches to pain management for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* Emphasize multimodal pain management &lt;br /&gt;
&lt;br /&gt;
=== Potential complications&amp;lt;!-- List and/or describe any potential postoperative complications for this case. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
* PONV&lt;br /&gt;
* Lymphedema&lt;br /&gt;
* Seroma&lt;br /&gt;
* Pneumothorax&lt;br /&gt;
&lt;br /&gt;
== Procedure variants&amp;lt;!-- This section should only be used for cases with multiple approaches (e.g. Laparoscopic vs. open appendectomy). Otherwise, remove this section. Use this table to very briefly compare and contrast various aspects between approaches. Add or remove rows as needed to maximize relevance. Consider using symbols rather than words when possible (e.g. +, –, additional symbols such as ↑ and ↓ are available using the &amp;quot;Ω&amp;quot; tool in the editor). --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!&lt;br /&gt;
!Total mastectomy&lt;br /&gt;
!Modified radical mastectomy&lt;br /&gt;
|-&lt;br /&gt;
|Unique considerations&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Position&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Surgical time&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|EBL&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Postoperative disposition&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Pain management&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Potential complications&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
[[Category:Surgical procedures]]&lt;/div&gt;</summary>
		<author><name>Huckfinne</name></author>
	</entry>
</feed>